Allen Cato III

Allen (Jo) Cato, III, Ph.D. is an accomplished drug development scientist with over 25 years of scientific expertise in pharmacokinetic study design, data analysis, modeling, simulations, and report authoring. Prior to joining VistaGen, Dr. Cato served as Vice President at Cato BioVentures actively pursuing business development opportunities and technology evaluation in preparation of business development proposals. Dr. Cato also held various positions at Cato Research, Ltd. (now Cato SMS), most recently as its Chief Operating Officer where he maintained overall strategic and operational responsibility of the company’s multiple locations, including implementing new programmatic strategic initiatives. Additional responsibilities have included acting as project manager or program director on project teams that have had numerous FDA submissions and several European Medicines Agency submissions and scientific reviewer of regulatory, clinical, and scientific documents within and outside areas of technical expertise. Dr. Cato previously held positions at Ligand Pharmaceuticals, Abbott Laboratories, and Research Triangle Pharmaceuticals. Dr. Cato earned a B.S. degree in Pharmacy and a Ph.D. in Biopharmaceutics from the University of North Carolina.